New Jersey, Nation Surpass Halfway Employment Recovery Mark

Rutgers researcher says progress will be much slower as rapid recovery phase wanes

Newswise — New Jersey gained back half of the jobs lost due to the coronavirus pandemic but a wide disparity remains between higher-income professionals working at home and lower-wage support workers still bearing the brunt of the economic downturn that has gripped the nation, according to a new Rutgers report.

This “two-lane recovery described as the Zoom and gloom” effect has made the pre-existing have/have-not divide much greater, say the authors of Coronavirus Economic Advances Wane: Fast Lane to Slow Lane in New Jersey and the Nation.

“The progress we have made in recovering from the pandemic-driven recession is still incomplete, especially when it comes to the economic scars that continue to assert their long-term impact,” says report co-author James W. Hughes, University Professor and dean emeritus of the Edward J. Bloustein School of Planning and Public Policy at Rutgers University-New Brunswick.

According to the report, New Jersey has regained 56.2 percent of the 831,300 jobs lost during the coronavirus-triggered downturn, leaving a deficit of 363,700 jobs. The nation has recovered 51.5 percent of the 22.16 million jobs it lost, with more than 10 million workers still unemployed.

“To put these gains in perspective, it took the nation 29 months, and New Jersey 51 months, to reach the halfway employment recovery mark following the 2007-2009 recession,” says Hughes.

Hughes said the sectors that gained the most jobs were those that had been hardest hit during the stay-at-home economic lockdown. To achieve full job recovery a much broader swath of the economy will have to be included, he said. 

The report also analyzes the population outmigration endemic to New Jersey and New York City. Before the coronavirus hit, New Jersey was losing 145 people per day to the rest of the country; New York City was losing 266 people per day. While data are not yet available, the current exodus from New Jersey and New York City will have a demonstrable effect on the state's economy, city and overall metropolitan region, the report says.

Hughes noted more local urban-suburban household movements will modify the effects.

“As we plan for a post-pandemic future, officials must give attention to complex and changing population migration flows,” Hughes said.

Coronavirus Economic Advances Wane: Fast Lane to Slow Lane in New Jersey and the Nation is the sixth report in a series of Fast Track Research Notes, published by the Rutgers Center for Advanced Infrastructure and Transportation on the pandemic’s economic fallout. The reports’ authors are Joseph J. Seneca, University Professor emeritus and Distinguished Professor of economics emeritus; Hughes; and Connie O. Hughes, former chief of management and policy in the New Jersey governor’s office.

The current report is available here.




Filters close

Showing results

110 of 4146
Newswise: Long-Term Impacts of COVID-19: Your Mental Health
Released: 25-Nov-2020 2:15 PM EST
Long-Term Impacts of COVID-19: Your Mental Health
Cedars-Sinai

The COVID-19 pandemic has shaped more than half a year of our lives, canceling plans, upending livelihoods and causing feelings of grief, stress and anxiety. And Cedars-Sinai mental health experts say the pandemic could be shaping our mental health well into the future.

Released: 25-Nov-2020 12:45 PM EST
SARS-CoV-2 mutations do not appear to increase transmissibility
University College London

None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a study led by UCL researchers.

Newswise: COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
Released: 25-Nov-2020 11:05 AM EST
COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
University of Alabama at Birmingham

Maryland-based Altimmune Inc., a clinical stage biopharmaceutical company, has submitted an Investigational New Drug, or IND, application to the United States Food and Drug Administration to commence a Phase 1 clinical study of its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.

Released: 25-Nov-2020 11:05 AM EST
BIDMC researchers reveal how genetic variations are linked to COVID-19 disease severity
Beth Israel Lahey Health

New research BIDMC-led sheds light on the genetic risk factors that make individuals more or less susceptible to severe COVID-19.

Newswise: blog-pandemic-scenario-planning-lg-feature2.jpg
Released: 25-Nov-2020 11:05 AM EST
Pandemic Ups Game on Scenario Planning in The Arts
Wallace Foundation

Researcher/Author of new toolkit and report seeks to help arts and culture organizations add scenario planning to their strategic toolbox

Released: 25-Nov-2020 10:30 AM EST
Young people's anxiety levels doubled during first COVID-19 lockdown, says study
University of Bristol

The number of young people with anxiety doubled from 13 per cent to 24 per cent, during the early stages of the COVID-19 pandemic and lockdown 1, according to new research from the University of Bristol.

Newswise: 249837_web.jpg
Released: 25-Nov-2020 10:20 AM EST
Tracking COVID-19 trends in hard-hit states
Louisiana State University

Currently, there are over 10 million confirmed cases and more than 240,000 casualties attributed to COVID-19 in the U.S.

Released: 25-Nov-2020 9:55 AM EST
More Health Systems Join National #MaskUp Campaign
Cleveland Clinic

Many more health systems are joining the national #MaskUp campaign encouraging Americans to stop the spread of COVID-19 by following safety guidelines. Over just a few days, another 19 health systems with hundreds of hospitals united with 100 health systems nationwide with hospitals numbering in the thousands. The public service campaign is critical to the health and well-being of all Americans. It is a plea from healthcare professionals everywhere: wear a mask and follow other precautions to save lives and help get our country back on its feet.

Newswise: delaterre_jpeg.jpg
Released: 25-Nov-2020 7:35 AM EST
Warwick scientists design model to predict cellular drug targets against Covid-19
University of Warwick

The covid-19 virus, like all viruses relies on their host for reproduction

access_time Embargo lifts in 2 days
Embargo will expire: 30-Nov-2020 10:00 AM EST Released to reporters: 24-Nov-2020 5:35 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 30-Nov-2020 10:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

110 of 4146

close
0.81925